The State Drug Administration issued a notice on measures to optimize full-life cycle supervision to support the innovation and development of high-end medical devices. Support the accelerated listing of high-end medical devices involved in industrial policies such as the National High Quality Development Action Plan. Strengthen registration guidance for artificial intelligence and biomaterials “top of the list” products, and cooperate with relevant departments to introduce medical device product support policies based on brain-computer interface technology. Explore the specific requirements for conditional approval for high-end medical devices that have been conditionally approved in accordance with the law.

The State Drug Administration issued a notice on measures to optimize full-life cycle supervision to support the innovation and development of high-end medical devices. Support the accelerated listing of high-end medical devices involved in industrial policies such as the National High Quality Development Action Plan. Strengthen registration guidance for artificial intelligence and biomaterials “top of the list” products, and cooperate with relevant departments to introduce medical device product support policies based on brain-computer interface technology. Explore the specific requirements for conditional approval for high-end medical devices that have been conditionally approved in accordance with the law.